Net Cash Provided by (Used in) Investing Activities in USD of ESSA Pharma Inc. from 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
ESSA Pharma Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2019 to Q4 2024.
  • ESSA Pharma Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2024 was -$3.93M, a 148% decline year-over-year.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $91.8M.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$3.53M, a 93.4% increase from 2022.
  • ESSA Pharma Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$53.1M, a 51.5% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)

ESSA Pharma Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$3.93M -$12.2M -148% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-11
Q4 2023 $8.23M +$9.73M Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-11
Q4 2022 -$1.49M +$9.51M +86.4% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q4 2021 -$11M -$11M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q4 2020 $0 Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03

ESSA Pharma Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $91.8M +$95.3M Oct 1, 2023 Sep 30, 2024 10-K 2024-12-17
2023 -$3.53M +$49.5M +93.4% Oct 1, 2022 Sep 30, 2023 10-K 2024-12-17
2022 -$53.1M -$18M -51.5% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-12
2021 -$35M -$13.3M -61.1% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-13
2020 -$21.7M -$21.9M -10893% Oct 1, 2019 Sep 30, 2020 10-K 2021-11-18
2019 $201K Oct 1, 2018 Sep 30, 2019 10-K 2021-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.